BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 23642997)

  • 1. Relationship between levels of angiogenic and lymphangiogenic factors and the endoscopic, histological and clinical activity, and acute-phase reactants in patients with inflammatory bowel disease.
    Algaba A; Linares PM; Fernández-Contreras ME; Ordoñez A; Trápaga J; Guerra I; Chaparro M; de la Poza G; Gisbert JP; Bermejo F
    J Crohns Colitis; 2013 Dec; 7(11):e569-79. PubMed ID: 23642997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is ischemia modified albumin a disease activity marker for inflammatory bowel diseases?
    Kaplan M; Yuksel M; Ates I; Kilic ZM; Kilic H; Kuzu UB; Kayacetin E
    J Gastroenterol Hepatol; 2016 Jun; 31(6):1120-5. PubMed ID: 26642816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-inflammatory effects of pancreatitis associated protein in inflammatory bowel disease.
    Gironella M; Iovanna JL; Sans M; Gil F; Peñalva M; Closa D; Miquel R; Piqué JM; Panés J
    Gut; 2005 Sep; 54(9):1244-53. PubMed ID: 15870231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of infliximab or adalimumab on vascular endothelial growth factor and angiopoietin 1 angiogenic factor levels in inflammatory bowel disease: serial observations in 37 patients.
    Algaba A; Linares PM; Encarnación Fernández-Contreras M; Figuerola A; Calvet X; Guerra I; de Pousa I; Chaparro M; Gisbert JP; Bermejo F
    Inflamm Bowel Dis; 2014 Apr; 20(4):695-702. PubMed ID: 24562175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of vascular endothelial growth factor and angiopoietin systems in serum of Crohn's disease patients.
    Pousa ID; Maté J; Salcedo-Mora X; Abreu MT; Moreno-Otero R; Gisbert JP
    Inflamm Bowel Dis; 2008 Jan; 14(1):61-7. PubMed ID: 17879276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated levels of serum-soluble triggering receptor expressed on myeloid cells-1 in patients with IBD do not correlate with intestinal TREM-1 mRNA expression and endoscopic disease activity.
    Saurer L; Rihs S; Birrer M; Saxer-Seculic N; Radsak M; Mueller C;
    J Crohns Colitis; 2012 Oct; 6(9):913-23. PubMed ID: 22410349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased production of vascular endothelial growth factor by intestinal mucosa of patients with inflammatory bowel disease.
    Griga T; Voigt E; Gretzer B; Brasch F; May B
    Hepatogastroenterology; 1999; 46(26):920-3. PubMed ID: 10370639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiogenesis as a novel component of inflammatory bowel disease pathogenesis.
    Danese S; Sans M; de la Motte C; Graziani C; West G; Phillips MH; Pola R; Rutella S; Willis J; Gasbarrini A; Fiocchi C
    Gastroenterology; 2006 Jun; 130(7):2060-73. PubMed ID: 16762629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired Intestinal Permeability Contributes to Ongoing Bowel Symptoms in Patients With Inflammatory Bowel Disease and Mucosal Healing.
    Chang J; Leong RW; Wasinger VC; Ip M; Yang M; Phan TG
    Gastroenterology; 2017 Sep; 153(3):723-731.e1. PubMed ID: 28601482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum interleukin-18 concentrations in patients with inflammatory bowel disease.
    Furuya D; Yagihashi A; Komatsu M; Masashi N; Tsuji N; Kobayashi D; Watanabe N
    J Immunother; 2002; 25 Suppl 1():S65-7. PubMed ID: 12048353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) expression and endoscopic activity in inflammatory bowel diseases.
    Jung YS; Park JJ; Kim SW; Hong SP; Kim TI; Kim WH; Cheon JH
    Dig Liver Dis; 2012 Nov; 44(11):897-903. PubMed ID: 22721842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel, objective, multivariate biomarkers composed of plasma amino acid profiles for the diagnosis and assessment of inflammatory bowel disease.
    Hisamatsu T; Okamoto S; Hashimoto M; Muramatsu T; Andou A; Uo M; Kitazume MT; Matsuoka K; Yajima T; Inoue N; Kanai T; Ogata H; Iwao Y; Yamakado M; Sakai R; Ono N; Ando T; Suzuki M; Hibi T
    PLoS One; 2012; 7(1):e31131. PubMed ID: 22303484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Necroptosis is active in children with inflammatory bowel disease and contributes to heighten intestinal inflammation.
    Pierdomenico M; Negroni A; Stronati L; Vitali R; Prete E; Bertin J; Gough PJ; Aloi M; Cucchiara S
    Am J Gastroenterol; 2014 Feb; 109(2):279-87. PubMed ID: 24322838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between serum interleukin-17 level and inflammatory bowel disease.
    Liu QL; Huang L; Zhao QJ; Li Q; He Z
    J Biol Regul Homeost Agents; 2016; 30(1):181-8. PubMed ID: 27049090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of inflammatory bowel disease activity in children using serum trefoil factor peptide.
    Teng X; Yang Y; Liu L; Yang L; Wu J; Sun M; Xu L
    Pediatr Res; 2020 Nov; 88(5):792-795. PubMed ID: 32120375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum VEGF and bFGF in patients with inflammatory bowel diseases.
    Kopanakis N; Saiti A; D'Avgerinos E; Masselou K; Simiri M; Mandaraka A; Vasiliadis G; Katergiannakis V
    Ann Ital Chir; 2014; 85(3):203-6. PubMed ID: 25073576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid fecal calprotectin level assessment and the SIBDQ score can accurately detect active mucosal inflammation in IBD patients in clinical remission: a prospective study.
    Voiosu T; Benguş A; Dinu R; Voiosu AM; Bălănescu P; Băicuş C; Diculescu M; Voiosu R; Mateescu B
    J Gastrointestin Liver Dis; 2014 Sep; 23(3):273-8. PubMed ID: 25267955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum tenascin-C is an indicator of inflammatory bowel disease activity.
    Riedl S; Tandara A; Reinshagen M; Hinz U; Faissner A; Bodenmüller H; Buhr HJ; Herfarth C; Möller P
    Int J Colorectal Dis; 2001 Sep; 16(5):285-91. PubMed ID: 11686525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum ST2 in inflammatory bowel disease: a potential biomarker for disease activity.
    Boga S; Alkim H; Koksal AR; Ozagari AA; Bayram M; Tekin Neijmann S; Sen I; Alkim C
    J Investig Med; 2016 Jun; 64(5):1016-24. PubMed ID: 27001944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Could platelet indices be new biomarkers for inflammatory bowel diseases?
    Öztürk ZA; Dag MS; Kuyumcu ME; Cam H; Yesil Y; Yilmaz N; Aydinli M; Kadayifci A; Kepekci Y
    Eur Rev Med Pharmacol Sci; 2013 Feb; 17(3):334-41. PubMed ID: 23426536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.